Home » Newsletters » BioWorld Science

BioWorld Science

March 4, 1998

View Archived Issues

Company Profile: ArQule

Company Profile: Avax Technologies

Cytogen: Q4 and year-end 1997 highlights

Cholera toxin enhances transcutaneous delivery, enabling development of needle-free vaccines

Acetaminophen increases risk of hemorrhage in combination with warfarin

Anika: year-end 1997 highlights

ArQule and Sepracor to optimize lead antiinfective compounds

Phase I results reported for alpha-gal in Fabry's disease

Status of Oncolym updated

J&J to withdraw from pramlintide collaboration; exendin update

Cell Therapeutics: Q4 and year-end 1997 highlights

University of Alabama describes delta-EKLFs for hemoglobinopathies

3-D reveals new trypsin-like serine protease inhibitors

Vaccines for group B meningococcal infection disclosed

Kowa product pipeline in review

Antidiabetic agents in development at Boehringer Mannheim

DiagnoCure signs agreements related to development of targeted nanoerythrosomes

More light shed on Lp(a) and its role in heart disease

Flavonoid intake reduces risk of death from CHD

Searle uses Epimmune technologies to develop cancer therapies

More on anti-HIV research at Glaxo Wellcome

BOPP will enter clinical testing in cancer patients

Gliadel Wafer approved for marketing in Brazil

Distribution and marketing of terfenadine-containing products discontinued in U.S.

Watson acquires Hoechst Marion Roussel's U.S. generic drug subsidiary

Efficacy of immunoliposomal amphotericin B confirmed in mice with invasive aspergillosis

Liposomal ciprofloxacin formulations demonstrate high efficacy and versatility

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...